Indian markets remain near record highs, but a sharp rupee fall and global volatility have raised red flags, says market expert Ajay Bagga. He warns that RBI’s absence during the currency slide could hurt FPI sentiment and delay rate cuts. A US–India trade deal remains the biggest potential trigger, while private-sector banks continue to look attractive
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma play
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and